David Kwinter Family Medicine & Urgent Care Physician Dr
These carriers can be engineered for surface modification with ligands targeting dopaminergic neurons or inflamed brain regions, enabling precision delivery and minimizing off-target toxicity (Naqvi et al., 2020
If their body mass index is in the 85th percentile or above and they have at least one chronic condition (known as comorbidity in medicine) such as high blood pressure or Type 2 diabetes, they can qualify
In the SURMOUNT-2 trial for adults with type 2 diabetes, tirzepatide 15 mg produced 14.7% mean weight loss at 72 weeks
GLP-1 medications like semaglutide and tirzepatide suppress appetite through receptor-level signaling in the brain and gut
Accordingly, it has been assumed that these genera could contribute to the development of cirrhosis and to a pro-inflammatory phenotype of cirrhosis, acting as pro-inflammatory triggers [51]